Ozempic, Wegovy, and Mounjaro are the three names most people encounter when they start researching medical weight loss. They’re related but not identical, and the right choice depends on your goals, your medical history, and what a doctor recommends after assessing you. Here’s a clear, side-by-side comparison.
The quick summary
- Ozempic (semaglutide) — a GLP-1 medication approved primarily for type 2 diabetes, widely used and well established.
- Wegovy (semaglutide) — the same active ingredient as Ozempic but dosed and approved specifically for weight management.
- Mounjaro (tirzepatide) — a newer dual GIP/GLP-1 medication that has shown the strongest average weight loss of the three in clinical trials.
How they work
Ozempic and Wegovy both contain semaglutide, which mimics the GLP-1 hormone to reduce appetite and slow stomach emptying. Mounjaro contains tirzepatide, which acts on two hormone pathways — GIP as well as GLP-1 — which is thought to explain its larger average weight-loss results.
Weight-loss results
In head-to-head and trial data, tirzepatide (Mounjaro) has generally produced greater average weight loss than semaglutide (Ozempic/Wegovy). Wegovy, because it’s dosed specifically for weight loss, tends to outperform Ozempic for that purpose. Individual results vary widely and depend on dose, consistency, diet, and activity.
Side effects
All three share a similar side-effect profile, most commonly nausea, reduced appetite, and digestive changes, especially when starting or increasing the dose. These usually ease over time and are minimised by titrating the dose slowly. A doctor will help you manage them.
Which one is right for you?
There’s no single “best” medication — there’s the one that’s best for you. The right choice depends on whether you have diabetes, how much weight you want to lose, how you tolerate side effects, availability, and cost. This decision should be made with a doctor who can assess your health and monitor your progress over time.
Frequently asked questions
Is Mounjaro better than Ozempic for weight loss?
On average, tirzepatide (Mounjaro) has shown greater weight loss than semaglutide (Ozempic) in studies, but the best option depends on your individual health profile and your doctor’s assessment.
What’s the difference between Ozempic and Wegovy?
They contain the same active ingredient (semaglutide). Ozempic is approved mainly for type 2 diabetes; Wegovy is dosed and approved specifically for weight management.
Can I switch between them?
Sometimes, under medical guidance. People may switch due to tolerance, results, or availability. Never switch or adjust dosing without your doctor.
This article is for general education and is not medical advice. These are prescription medicines that should only be used under the supervision of a qualified doctor.